| Regulatory dendritic cells for promotion of liver transplant operational tolerance: Rationale for a clinical trial and accompanying mechanistic studies |
20 |
| Tolerance in clinical liver transplantation |
15 |
| Evidence for M2 macrophages in granulomas from pulmonary sarcoidosis: A new aspect of macrophage heterogeneity |
14 |
| pHLA3D: An online database of predicted three-dimensional structures of HLA molecules |
13 |
| Mesenchymal stromal cells for tolerance induction in organ transplantation |
12 |
| Increased frequency and FOXP3 expression of human CD8(+)CD25(High+) T lymphocytes and its relation to CD4 regulatory T cells in patients with hepatocellular carcinoma |
11 |
| Influence of ERAP1 and ERAP2 gene polymorphisms on disease susceptibility in different populations |
10 |
| CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment |
10 |
| Preclinical and clinical studies for transplant tolerance via the mixed chimerism approach |
10 |
| Regulatory T cells for tolerance |
10 |
| Anti-vimentin antibodies in transplant and disease |
9 |
| The MHC in the era of next-generation sequencing: Implications for bridging structure with function |
9 |
| HLA-G mediated immune regulation is impaired by a single amino acid exchange in the alpha 2 domain |
9 |
| CD8(+)CXCR5(+) T cells in tumor-draining lymph nodes are highly activated and predict better prognosis in colorectal cancer |
9 |
| Peptide trimming by endoplasmic reticulum aminopeptidases: Role of MHC class I binding and ERAP dimerization |
8 |
| Epigenetics and pathogenesis of systemic sclerosis; the ins and outs |
8 |
| B cells in chronic graft-versus-host disease |
8 |
| Antibodies against Angiotensin II Type 1 and Endothelin A Receptors: Relevance and pathogenicity |
8 |
| Biomarkers of operational tolerance following kidney transplantation - The immune tolerance network studies of spontaneously tolerant kidney transplant recipients |
8 |
| The genetic polymorphism and expression profiles of NLRP3 inflammasome in patients with chronic myeloid leukemia |
7 |
| Tissue-associated self-antigens containing exosomes: Role in allograft rejection |
7 |
| Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: The importance of durable chimerism |
7 |
| Biomarkers of immune tolerance in liver transplantation |
7 |
| The ABCs (DRDQDPs) of the prozone effect in single antigen bead HLA antibody testing: Lessons from our highly sensitized patients |
7 |
| Impact of persistent and cleared preformed HLA DSA on kidney transplant outcomes |
7 |
| Pre-transplant Screening for Non-HLA Antibodies: Who should be Tested? |
7 |
| Regulation of ERAP1 and ERAP2 genes and their disfunction in human cancer |
7 |
| Next-generation sequencing reveals new information about HLA allele and haplotype diversity in a large European American population |
6 |
| Second update of the International Registry of HLA Epitopes. I. The HLA-ABC Epitope Database |
6 |
| Predicting an HLA-DPB1 expression marker based on standard DPB1 genotyping: Linkage analysis of over 000 samples |
6 |
| Rapid optimized flow cytometric crossmatch (FCXM) assays: The Halifax and Halifaster protocols |
6 |
| Increased T cell immunosenescence and accelerated maturation phenotypes Check for in older kidney transplant recipients |
6 |
| Implications of uterine NK cells and regulatory T cells in the endometrium of infertile women |
6 |
| Hla-mapper: An application to optimize the mapping of HLA sequences produced by massively parallel sequencing procedures |
6 |
| IL-8 analogue CXCL8 (3-72) K11R/G31P, modulates LPS-induced inflammation via AKT1-NF-k beta and ERK1/2-AP-1 pathways in THP-1 monocytes |
6 |
| B cell MHC class II signaling: A story of life and death |
6 |
| Quality control project of NGS HLA genotyping for the 17th International HLA and Immunogenetics Workshop |
6 |
| Gene variants in the NF-KB pathway (NFKB NFKBIA, NFKBIZ) and their association with type 2 diabetes and impaired renal function |
6 |
| Degree of HLA class II eplet mismatch load improves prediction of antibody-mediated rejection in living donor kidney transplantation |
6 |
| Exosomes derived from mesenchymal stem cells improved function and survival of neutrophils from severe congenital neutropenia patients in vitro |
6 |
| 10-Year Experience with HLA-G in Heart Transplantation |
6 |
| Genetic association between HLA-G 14-bp polymorphism and diseases: A systematic review and meta-analysis |
5 |
| (F)Utility of the physical crossmatch for living donor evaluations in the age of the virtual crossmatch |
5 |
| Immunotherapy in pediatric B-cell acute lymphoblastic leukemia |
5 |
| Anti-donor regulatory T cell therapy in liver transplantation |
5 |
| Sensitization to endothelial cell antigens: Unraveling the cause or effect paradox |
5 |
| Immune monitoring of transplant patients in transient mixed chimerism tolerance trials |
5 |
| Prevalence of autoimmune diseases and clinical significance of autoantibody profile: Data from National Institute of Hygiene in Rabat, Morocco |
5 |
| Towards the identification of the relative immunogenicity of individual HLA antibody epitopes |
5 |
| Clinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma |
5 |
